Cargando…
Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE study
BACKGROUND: Prevalence of inflammatory bowel disease (IBD) is increasing in China. The EXPLORE study evaluated the incidence and indicators of suboptimal responses to first-line anti-tumor necrosis factor (TNF) in patients with ulcerative colitis (UC) or Crohn’s disease (CD). We present results for...
Autores principales: | Li, Ji, Liu, Zhanju, Hu, Pinjin, Wen, Zhonghui, Cao, Qian, Zou, Xiaoping, Chen, Yan, Wang, Yingde, Zhong, Jie, Shen, Xizhong, Demuth, Dirk, Fadeeva, Olga, Xie, Li, Chen, Jun, Qian, Jiaming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817491/ https://www.ncbi.nlm.nih.gov/pubmed/35120446 http://dx.doi.org/10.1186/s12876-021-02074-z |
Ejemplares similares
-
Targeted versus universal tuberculosis chemoprophylaxis in 1968 patients with inflammatory bowel disease receiving anti‐TNF therapy in a tuberculosis endemic region
por: Ye, Lingna, et al.
Publicado: (2020) -
Incidence and risk factors for venous thrombosis among patients with inflammatory bowel disease in China: a multicenter retrospective study
por: Liu, Jing, et al.
Publicado: (2021) -
The Incidence of Inflammatory Bowel Disease in Northern China: A Prospective Population-Based Study
por: Yang, Hong, et al.
Publicado: (2014) -
Interplay of intestinal microbiota and mucosal immunity in
inflammatory bowel disease: a relationship of
frenemies
por: Chen, Huimin, et al.
Publicado: (2020) -
Small bowel necrosis after esophagectomy
por: Shao, Longlong, et al.
Publicado: (2023)